Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1972 Nov;46(3):395–400. doi: 10.1111/j.1476-5381.1972.tb08136.x

Effect of prostaglandins E1, E2 and A2 on vascular resistance and responses to noradrenaline, nerve stimulation and angiotensin in the dog hindlimb

Philip J Kadowitz
PMCID: PMC1666530  PMID: 4348179

Abstract

1. The relationship between the vasodilator and inhibitory effects of prostaglandin E1 (PGE1), E2 and A2 on responses to nerve stimulation, noradrenaline and angiotensin was evaluated in the dog hindlimb preparation.

2. PGE1 and PGE2 were equipotent as vasodilators in the hindlimb; however, PGE1 was much more potent as an inhibitor of vasoconstrictor responses to nerve stimulation, noradrenaline and angiotensin.

3. PGA2 and PGE2 were approximately equal as inhibitors of vasoconstrictor responses to noradrenaline, nerve stimulation and angiotensin; however, PGE2 was far more potent as a vasodilator.

4. Since there is no relationship between the vasodilator and inhibitory effects of PGE1, E2 and A2, and since the inhibitory effect of PGA2 was present at a time when hindlimb perfusion pressure had returned to control value, it is concluded that the inhibitory action is probably not the result of a physiological antagonism.

5. Since each prostaglandin inhibited responses to nerve stimulation and noradrenaline to approximately the same extent and responses to angiotensin were also inhibited, it is suggested that these agents antagonize vasoconstrictor responses by a nonspecific depressant effect on smooth muscle cells.

Full text

PDF
398

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlson L. A., Orö L. Effect of prostaglandin E1 on blood pressure and heart rate in the dog. Prostaglandin and related factors 48. Acta Physiol Scand. 1966 May;67(1):89–99. doi: 10.1111/j.1748-1716.1966.tb03290.x. [DOI] [PubMed] [Google Scholar]
  2. Davies B. N., Horton E. W., Withrington P. G. The occurrence of prostaglandin E2 in splenic venous blood of the dog following splenic nerve stimulation. Br J Pharmacol Chemother. 1968 Jan;32(1):127–135. doi: 10.1111/j.1476-5381.1968.tb00436.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davies B. N., Withrington P. G. The effects of prostaglandins E1 and E2 on the smooth muscle of the dog spleen and on its responses to catecholamines, angiotensin and nerve stimulation. Br J Pharmacol Chemother. 1968 Jan;32(1):136–144. doi: 10.1111/j.1476-5381.1968.tb00437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dunham E. W., Zimmerman B. G. Release of prostaglandin-like material from dog kidney during nerve stimulation. Am J Physiol. 1970 Nov;219(5):1279–1285. doi: 10.1152/ajplegacy.1970.219.5.1279. [DOI] [PubMed] [Google Scholar]
  5. Gilmore N., Vane J. R., Wyllie J. H. Prostaglandins released by the spleen. Nature. 1968 Jun 22;218(5147):1135–1140. doi: 10.1038/2181135a0. [DOI] [PubMed] [Google Scholar]
  6. HOLMES S. W., HORTON E. W., MAIN I. H. THE EFFECT OF PROSTAGLANDIN E1 ON RESPONSES OF SMOOTH MUSCLE TO CATECHOL AMINES, ANGIOTENSIN AND VASOPRESSIN. Br J Pharmacol Chemother. 1963 Dec;21:538–543. doi: 10.1111/j.1476-5381.1963.tb02021.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hedqvist P., Brundin J. Inhibition by prostaglandin E1 of noradrenaline release and of effector response to nerve stimulation in the cat spleen. Life Sci. 1969 Apr 1;8(7):389–395. doi: 10.1016/0024-3205(69)90232-x. [DOI] [PubMed] [Google Scholar]
  8. Hedqvist P. Control by prostaglandin E2 of sympathetic neurotrans-mission in the spleen. Life Sci. 1970 Mar 1;9(5):269–278. doi: 10.1016/0024-3205(70)90028-7. [DOI] [PubMed] [Google Scholar]
  9. Hedwall P. R., Abdel-Sayed W. A., Schmid P. G., Abboud F. M. Inhibition of venoconstrictor responses by prostaglandin E1. Proc Soc Exp Biol Med. 1970 Dec;135(3):757–759. doi: 10.3181/00379727-135-35137. [DOI] [PubMed] [Google Scholar]
  10. Hedwall P. R., Abdel-Sayed W. A., Schmid P. G., Mark A. L., Abboud F. M. Vascular responses to prostaglandin E1 in gracilis muscle and hindpaw of the dog. Am J Physiol. 1971 Jul;221(1):42–47. doi: 10.1152/ajplegacy.1971.221.1.42. [DOI] [PubMed] [Google Scholar]
  11. Kadowitz P. J., Sweet C. S., Brody M. J. Blockade of adrenergic vasoconstrictor responses in the dog by prostaglandins E 1 and A 1 . J Pharmacol Exp Ther. 1971 Dec;179(3):563–572. [PubMed] [Google Scholar]
  12. Kadowitz P. J., Sweet C. S., Brody M. J. Potentiation of adrenergic venomotor responses by angiotensin, prostaglandin F 2 and cocaine. J Pharmacol Exp Ther. 1971 Jan;176(1):167–173. [PubMed] [Google Scholar]
  13. McGiff J. C., Crowshaw K., Terragno N. A., Lonigro A. J. Release of a prostaglandin-like substance into renal venous blood in response to angiotensin II. Circ Res. 1970 Jul;27(1 Suppl 1):121–130. [PubMed] [Google Scholar]
  14. Nakano J., McCurdy J. R. Cardiovascular effects of prostaglandin E1. J Pharmacol Exp Ther. 1967 Jun;156(3):538–547. [PubMed] [Google Scholar]
  15. Sweet C. S., Kadowitz P. J., Brody M. J. Another humoral substance that enhances adrenergic responsiveness during acute renal ischaemia. Nature. 1971 May 28;231(5300):263–265. doi: 10.1038/231263a0. [DOI] [PubMed] [Google Scholar]
  16. Viguera M. G., Sunahara F. A. Microcirculatory effects of prostaglandins. Can J Physiol Pharmacol. 1969 Jul;47(7):627–634. doi: 10.1139/y69-109. [DOI] [PubMed] [Google Scholar]
  17. Weiner R., Kaley G. Influence of prostaglandin E1 on the terminal vascular bed. Am J Physiol. 1969 Aug;217(2):563–566. doi: 10.1152/ajplegacy.1969.217.2.563. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES